Titration Study of ABX-1431

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

May 7, 2019

Study Completion Date

May 7, 2019

Conditions

Post Herpetic NeuralgiaDiabetic Peripheral NeuropathySmall Fiber NeuropathyPost-Traumatic Neuralgia

Interventions

DRUG

ABX-1431

Capsules of either 2mg, 10mg, or 50mg

DRUG

Placebo oral capsule

placebo to match

Trial Locations (1)

Republican Clinical Hospital, Chisinau